Ms. Sherwood was appointed to the Board on March 31, 2022. Since January 2017, Ms. Sherwood has been the owner of Scienta Communications, LLC, an independent communications consultancy established in 2010 to provide strategic public relations and corporate communications counsel to pre-commercial, public and private life sciences companies. In this capacity, she has provided strategic communications and crisis management counsel to biotechnology and medical device executives. On a day-to-day basis, she provides tactical support including development of materials and coordination of events, conference calls and webcasts, supports client milestones with media outreach and provides strategic counsel to enhance the company’s perception on Wall Street and in industry.
Earlier in her career, Ms. Sherwood managed corporate communications for The Liposome Company. During the subsequent decade, she worked at a series of global and boutique public and investor relations agencies where she provided support for companies pursuing a variety of indications including oncology. Through these combined experiences, Ms. Sherwood developed a general knowledge of the research and development process, and an understanding of the potential of delivery technologies to enhance oncology drug development.